FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2093452022> ?p ?o ?g. }

• W2093452022 endingPage "4643" @default.
• W2093452022 startingPage "4635" @default.
• W2093452022 abstract "The immunogenicity and safety of a chromatographically purified rabies vaccine (CPRV) was evaluated using US veterinary medical students. In the first study, 242 healthy adults were enrolled in a randomized, modified double-blind, multicenter trial and received five doses of either CPRV or human diploid cell vaccine (HDCV) by intramuscular injection on days 0, 3, 7, 14, and 28 concurrently with human rabies immunoglobulin in a simulated post-exposure prophylaxis regimen. Post-immunization titers in the CPRV and HDCV groups reached 0.5 IU/ml (the WHO-recommended minimally acceptable titer) or greater in all subjects in both vaccine groups by day 14 and remained above that level through day 90. In the second study, 438 healthy adults were enrolled in a randomized, double-blind, multicenter trial and assigned to receive five doses from one of three lots of CPRV by intramuscular injection on days 0, 3, 7, 14, and 28 in a simulated post-exposure prophylaxis regimen to evaluate lot consistency. Post-immunization titers rapidly increased to over 0.5 IU/ml by day 14 for all subjects and remained above that level through day 42 when the study was terminated. The three lots were considered equivalent. The percentage of subjects with at least one local reaction during the five-dose regimen was slightly lower in the CPRV group than in the HDCV group (P=0.06). The most frequently reported local reaction for all doses of vaccine was pain at the injection site. Headache, myalgia, and malaise were the most frequently reported systemic events. The percentage of subjects with at least one systemic event was significantly lower for CPRV (P=0.0084). No vaccine-related serious adverse reaction was reported in these studies. The results of these studies indicate that CPRV administered intramuscularly to healthy adults is immunogenic and is associated with fewer local and systemic reactions than HDCV." @default.
• W2093452022 created "2016-06-24" @default.
• W2093452022 creator A5000299277 @default.
• W2093452022 creator A5001978364 @default.
• W2093452022 creator A5007045861 @default.
• W2093452022 creator A5016438034 @default.
• W2093452022 creator A5018375309 @default.
• W2093452022 creator A5019677521 @default.
• W2093452022 creator A5034527205 @default.
• W2093452022 creator A5044257209 @default.
• W2093452022 creator A5077573248 @default.
• W2093452022 creator A5080413492 @default.
• W2093452022 creator A5082406700 @default.
• W2093452022 date "2001-09-01" @default.
• W2093452022 modified "2023-10-14" @default.
• W2093452022 title "Immunogenicity, safety and lot consistency in adults of a chromatographically purified Vero-cell rabies vaccine: a randomized, double-blind trial with human diploid cell rabies vaccine" @default.
• W2093452022 cites W1977648801 @default.
• W2093452022 cites W1993022851 @default.
• W2093452022 cites W1998519227 @default.
• W2093452022 cites W2005154353 @default.
• W2093452022 cites W2012622509 @default.
• W2093452022 cites W2028874740 @default.
• W2093452022 cites W2030935899 @default.
• W2093452022 cites W2036489279 @default.
• W2093452022 cites W2073009282 @default.
• W2093452022 cites W2075937525 @default.
• W2093452022 cites W2331479651 @default.
• W2093452022 doi "https://doi.org/10.1016/s0264-410x(01)00238-9" @default.
• W2093452022 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11535311" @default.
• W2093452022 hasPublicationYear "2001" @default.
• W2093452022 type Work @default.
• W2093452022 sameAs 2093452022 @default.
• W2093452022 citedByCount "38" @default.
• W2093452022 countsByYear W20934520222012 @default.
• W2093452022 countsByYear W20934520222013 @default.
• W2093452022 countsByYear W20934520222014 @default.
• W2093452022 countsByYear W20934520222017 @default.
• W2093452022 countsByYear W20934520222018 @default.
• W2093452022 countsByYear W20934520222019 @default.
• W2093452022 countsByYear W20934520222020 @default.
• W2093452022 countsByYear W20934520222022 @default.
• W2093452022 countsByYear W20934520222023 @default.
• W2093452022 crossrefType "journal-article" @default.
• W2093452022 hasAuthorship W2093452022A5000299277 @default.
• W2093452022 hasAuthorship W2093452022A5001978364 @default.
• W2093452022 hasAuthorship W2093452022A5007045861 @default.
• W2093452022 hasAuthorship W2093452022A5016438034 @default.
• W2093452022 hasAuthorship W2093452022A5018375309 @default.
• W2093452022 hasAuthorship W2093452022A5019677521 @default.
• W2093452022 hasAuthorship W2093452022A5034527205 @default.
• W2093452022 hasAuthorship W2093452022A5044257209 @default.
• W2093452022 hasAuthorship W2093452022A5077573248 @default.
• W2093452022 hasAuthorship W2093452022A5080413492 @default.
• W2093452022 hasAuthorship W2093452022A5082406700 @default.
• W2093452022 hasConcept C126322002 @default.
• W2093452022 hasConcept C159047783 @default.
• W2093452022 hasConcept C159654299 @default.
• W2093452022 hasConcept C168563851 @default.
• W2093452022 hasConcept C203014093 @default.
• W2093452022 hasConcept C22070199 @default.
• W2093452022 hasConcept C2776849203 @default.
• W2093452022 hasConcept C2777961786 @default.
• W2093452022 hasConcept C2778283251 @default.
• W2093452022 hasConcept C2778616394 @default.
• W2093452022 hasConcept C2780674857 @default.
• W2093452022 hasConcept C2780801004 @default.
• W2093452022 hasConcept C2780868878 @default.
• W2093452022 hasConcept C2781413609 @default.
• W2093452022 hasConcept C32611913 @default.
• W2093452022 hasConcept C71924100 @default.
• W2093452022 hasConceptScore W2093452022C126322002 @default.
• W2093452022 hasConceptScore W2093452022C159047783 @default.
• W2093452022 hasConceptScore W2093452022C159654299 @default.
• W2093452022 hasConceptScore W2093452022C168563851 @default.
• W2093452022 hasConceptScore W2093452022C203014093 @default.
• W2093452022 hasConceptScore W2093452022C22070199 @default.
• W2093452022 hasConceptScore W2093452022C2776849203 @default.
• W2093452022 hasConceptScore W2093452022C2777961786 @default.
• W2093452022 hasConceptScore W2093452022C2778283251 @default.
• W2093452022 hasConceptScore W2093452022C2778616394 @default.
• W2093452022 hasConceptScore W2093452022C2780674857 @default.
• W2093452022 hasConceptScore W2093452022C2780801004 @default.
• W2093452022 hasConceptScore W2093452022C2780868878 @default.
• W2093452022 hasConceptScore W2093452022C2781413609 @default.
• W2093452022 hasConceptScore W2093452022C32611913 @default.
• W2093452022 hasConceptScore W2093452022C71924100 @default.
• W2093452022 hasIssue "32" @default.
• W2093452022 hasLocation W20934520221 @default.
• W2093452022 hasLocation W20934520222 @default.
• W2093452022 hasOpenAccess W2093452022 @default.
• W2093452022 hasPrimaryLocation W20934520221 @default.
• W2093452022 hasRelatedWork W1981491337 @default.
• W2093452022 hasRelatedWork W2047456470 @default.
• W2093452022 hasRelatedWork W2055580608 @default.
• W2093452022 hasRelatedWork W2124173691 @default.
• W2093452022 hasRelatedWork W2356833754 @default.
• W2093452022 hasRelatedWork W3120730327 @default.
• W2093452022 hasRelatedWork W3144031950 @default.

• next